Effect of lymphokine-activated killer cells on human retinoblastoma cells (Y-79) in vitro: Enhancement of the activity by a polysaccharide preparation, krestin
- 15 January 1991
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 174 (1) , 107-114
- https://doi.org/10.1016/0006-291x(91)90492-p
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Lymphokine-Activated Killer Cytotoxicity in Neonatal Mononuclear Cells: In Vitro Responses to Tumor Cell Lines from Pediatric Solid Tumors1Pediatric Research, 1989
- Cytotoxic studies in human newborns: Lessened allogeneic cell-induced (augmented) cytotoxicity but strong lymphokine-activated cytotoxicity of cord mononuclear cellsCellular Immunology, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- The use of chemotherapy for extraocular retinoblastomaMedical and Pediatric Oncology, 1985
- Krestin (PSK)Cancer Treatment Reviews, 1984
- The role of a gamma interferon-like lymphokine in the activation of T cells for expression of interleukin 2 receptorsCellular Immunology, 1983
- THE ROLE OF CHEMOTHERAPY IN THE TREATMENT OF RETINOBLASTOMARetina, 1983
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Deficiency of immune interferon production by leukocytes of normal newbornsCellular Immunology, 1980